• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾结石病的代谢变化。

Metabolic changes in kidney stone disease.

机构信息

Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Immunol. 2023 May 9;14:1142207. doi: 10.3389/fimmu.2023.1142207. eCollection 2023.

DOI:10.3389/fimmu.2023.1142207
PMID:37228601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10203412/
Abstract

Kidney stone disease (KSD) is one of the earliest medical diseases known, but the mechanism of its formation and metabolic changes remain unclear. The formation of kidney stones is a extensive and complicated process, which is regulated by metabolic changes in various substances. In this manuscript, we summarized the progress of research on metabolic changes in kidney stone disease and discuss the valuable role of some new potential targets. We reviewed the influence of metabolism of some common substances on stone formation, such as the regulation of oxalate, the release of reactive oxygen species (ROS), macrophage polarization, the levels of hormones, and the alternation of other substances. New insights into changes in substance metabolism changes in kidney stone disease, as well as emerging research techniques, will provide new directions in the treatment of stones. Reviewing the great progress that has been made in this field will help to improve the understanding by urologists, nephrologists, and health care providers of the metabolic changes in kidney stone disease, and contribute to explore new metabolic targets for clinical therapy.

摘要

肾结石病(KSD)是最早被发现的医学疾病之一,但结石形成的机制和代谢变化仍不清楚。肾结石的形成是一个广泛而复杂的过程,受各种物质代谢变化的调节。在本手稿中,我们总结了肾结石病代谢变化研究的进展,并讨论了一些新的潜在靶点的有价值作用。我们综述了一些常见物质的代谢对结石形成的影响,如草酸盐的调节、活性氧(ROS)的释放、巨噬细胞极化、激素水平以及其他物质的变化。对肾结石病物质代谢变化的新认识,以及新兴的研究技术,将为结石的治疗提供新的方向。回顾该领域取得的巨大进展,将有助于泌尿科医生、肾病学家和医疗保健提供者更好地了解肾结石病的代谢变化,并有助于探索临床治疗的新代谢靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/5880042be30a/fimmu-14-1142207-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/ad0af4a66436/fimmu-14-1142207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/ebf9d21fd8e2/fimmu-14-1142207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/50988873e646/fimmu-14-1142207-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/5880042be30a/fimmu-14-1142207-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/ad0af4a66436/fimmu-14-1142207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/ebf9d21fd8e2/fimmu-14-1142207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/50988873e646/fimmu-14-1142207-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8e/10203412/5880042be30a/fimmu-14-1142207-g004.jpg

相似文献

1
Metabolic changes in kidney stone disease.肾结石病的代谢变化。
Front Immunol. 2023 May 9;14:1142207. doi: 10.3389/fimmu.2023.1142207. eCollection 2023.
2
The advances of calcium oxalate calculi associated drugs and targets.草酸钙结石相关药物和靶点的研究进展。
Eur J Pharmacol. 2022 Nov 15;935:175324. doi: 10.1016/j.ejphar.2022.175324. Epub 2022 Oct 17.
3
Recent advances on the mechanisms of kidney stone formation (Review).肾结石形成机制的最新进展(综述)
Int J Mol Med. 2021 Aug;48(2). doi: 10.3892/ijmm.2021.4982. Epub 2021 Jun 16.
4
Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease.草酸盐代谢:从肾结石到心血管疾病。
Mayo Clin Proc. 2024 Jul;99(7):1149-1161. doi: 10.1016/j.mayocp.2024.02.006. Epub 2024 May 17.
5
The impact of dietary oxalate on kidney stone formation.饮食中草酸盐对肾结石形成的影响。
Urol Res. 2004 Oct;32(5):311-6. doi: 10.1007/s00240-004-0437-3. Epub 2004 Jun 17.
6
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
7
Dietary oxalate and kidney stone formation.饮食草酸盐与肾结石形成。
Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409-F413. doi: 10.1152/ajprenal.00373.2018. Epub 2018 Dec 19.
8
Oxalate: from the environment to kidney stones.草酸盐:从环境到肾结石
Arh Hig Rada Toksikol. 2013 Dec;64(4):609-30. doi: 10.2478/10004-1254-64-2013-2428.
9
Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.活性氧作为草酸钙肾结石形成的分子调节剂:来自临床和实验研究的证据。
J Urol. 2013 Mar;189(3):803-11. doi: 10.1016/j.juro.2012.05.078. Epub 2012 Sep 25.
10
Calcium oxalate stone disease: congenital defect of metabolism?草酸钙结石病:先天性代谢缺陷?
J Urol. 1976 Dec;116(6):687-9. doi: 10.1016/s0022-5347(17)58971-5.

引用本文的文献

1
Gut microbiota-regulated unconjugated bilirubin metabolism drives renal calcium oxalate crystal deposition.肠道微生物群调节的未结合胆红素代谢驱动肾草酸钙晶体沉积。
Gut Microbes. 2025 Dec;17(1):2546158. doi: 10.1080/19490976.2025.2546158. Epub 2025 Aug 24.
2
Unraveling the gut-immune-kidney axis in kidney stone disease: a two-step Mendelian randomization investigation.解析肾结石疾病中的肠道-免疫-肾脏轴:一项两步孟德尔随机化研究
Urolithiasis. 2025 Aug 20;53(1):160. doi: 10.1007/s00240-025-01830-0.
3
Differences in macrophage pyroptosis and polarization induced by nano-/micro-calcium oxalate crystals.

本文引用的文献

1
Metformin suppresses calcium oxalate crystal-induced kidney injury by promoting Sirt1 and M2 macrophage-mediated anti-inflammatory activation.二甲双胍通过促进Sirt1和M2巨噬细胞介导的抗炎激活来抑制草酸钙晶体诱导的肾损伤。
Signal Transduct Target Ther. 2023 Jan 27;8(1):38. doi: 10.1038/s41392-022-01232-3.
2
Urinary Microbial and Metabolomic Profiles in Kidney Stone Disease.尿微生物和代谢组学特征在肾结石病中的研究。
Front Cell Infect Microbiol. 2022 Sep 5;12:953392. doi: 10.3389/fcimb.2022.953392. eCollection 2022.
3
Lactiplantibacillus plantarum J-15 reduced calcium oxalate kidney stones by regulating intestinal microbiota, metabolism, and inflammation in rats.
纳米/微米级草酸钙晶体诱导的巨噬细胞焦亡和极化差异。
J Nanobiotechnology. 2025 Jul 10;23(1):499. doi: 10.1186/s12951-025-03549-x.
4
Outpatient crystalluria: prevalence, crystal types, and associations with comorbidities and urinary tract infections at a provincial hospital.门诊结晶尿症:某省级医院的患病率、晶体类型及其与合并症和尿路感染的关联
Iran J Microbiol. 2025 Jun;17(3):382-389. doi: 10.18502/ijm.v17i3.18820.
5
Identification of aging-related biomarkers and immune infiltration analysis in renal stones by integrated bioinformatics analysis.通过综合生物信息学分析鉴定肾结石中与衰老相关的生物标志物并进行免疫浸润分析。
Sci Rep. 2025 Jul 1;15(1):21650. doi: 10.1038/s41598-025-05087-w.
6
Exploring the impact of PFAS exposure and sleep duration on kidney stone formation in the U.S. population.探究全氟和多氟烷基物质(PFAS)暴露及睡眠时间对美国人群肾结石形成的影响。
Front Public Health. 2025 Jun 4;13:1606191. doi: 10.3389/fpubh.2025.1606191. eCollection 2025.
7
Roles of ACSL4/GPX4 and FSP1 in oxalate-induced acute kidney injury.ACSL4/GPX4和FSP1在草酸盐诱导的急性肾损伤中的作用。
Cell Death Discov. 2025 Jun 17;11(1):279. doi: 10.1038/s41420-025-02557-y.
8
Balancing Stone Prevention and Kidney Function: A Therapeutic Dilemma.平衡结石预防与肾功能:一个治疗困境
J Clin Med. 2025 May 23;14(11):3678. doi: 10.3390/jcm14113678.
9
Causal relationship between basal metabolic rate and kidney stone disease: from discovery in US NHANES to evidence in UK Biobank cohorts.基础代谢率与肾结石疾病之间的因果关系:从美国国家健康与营养检查调查(NHANES)中的发现到英国生物银行队列研究中的证据
Int J Surg. 2025 Jun 10;111(9):6063-74. doi: 10.1097/JS9.0000000000002658.
10
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.药物性肾结石:一项使用美国食品药品监督管理局不良事件报告系统数据库的真实世界药物警戒研究。
Front Pharmacol. 2025 Mar 27;16:1511115. doi: 10.3389/fphar.2025.1511115. eCollection 2025.
植物乳杆菌 J-15 通过调节大鼠肠道微生物群、代谢和炎症来减少草酸钙肾结石。
FASEB J. 2022 Jun;36(6):e22340. doi: 10.1096/fj.202101972RR.
4
Estrogen treatment reduced oxalate transporting activity and enhanced migration through the involvement of SLC26A6 in lung cancer cells.雌激素治疗通过涉及肺癌细胞中的 SLC26A6 降低草酸盐转运活性并增强迁移。
Toxicol In Vitro. 2022 Aug;82:105373. doi: 10.1016/j.tiv.2022.105373. Epub 2022 Apr 29.
5
Role of ROS-Induced NLRP3 Inflammasome Activation in the Formation of Calcium Oxalate Nephrolithiasis.活性氧诱导的 NLRP3 炎性小体激活在草酸钙肾结石形成中的作用。
Front Immunol. 2022 Jan 27;13:818625. doi: 10.3389/fimmu.2022.818625. eCollection 2022.
6
Exosomes derived from calcium oxalate-treated macrophages promote apoptosis of HK-2 cells by promoting autophagy.钙草酸处理的巨噬细胞来源的外泌体通过促进自噬促进 HK-2 细胞凋亡。
Bioengineered. 2022 Feb;13(2):2442-2450. doi: 10.1080/21655979.2021.2012622.
7
Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter SLC26A6.短链脂肪酸通过调节肠道草酸转运体SLC26A6的表达减少肾草酸钙结石。
mSystems. 2021 Dec 21;6(6):e0104521. doi: 10.1128/mSystems.01045-21. Epub 2021 Nov 16.
8
Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.短链脂肪酸通过 GPR43 依赖的免疫调节机制预防乙醛酸盐诱导的草酸钙结石。
Front Immunol. 2021 Oct 5;12:729382. doi: 10.3389/fimmu.2021.729382. eCollection 2021.
9
Short-chain fatty acids as modulators of redox signaling in health and disease.短链脂肪酸作为健康和疾病中氧化还原信号的调节剂。
Redox Biol. 2021 Nov;47:102165. doi: 10.1016/j.redox.2021.102165. Epub 2021 Oct 14.
10
Oxalate Activates Autophagy to Induce Ferroptosis of Renal Tubular Epithelial Cells and Participates in the Formation of Kidney Stones.草酸盐通过激活自噬诱导肾小管上皮细胞发生铁死亡并参与肾结石的形成。
Oxid Med Cell Longev. 2021 Oct 6;2021:6630343. doi: 10.1155/2021/6630343. eCollection 2021.